<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0">
<channel>
<title>Abbott MediaRoom (Business)</title>
<link>https://abbott.mediaroom.com/</link>
<description></description>
<item>
<title>Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance</title>
<link>https://abbott.mediaroom.com/2026-10-21-Abbott-Reports-Third-Quarter-2026-Results-and-Reaffirms-Full-Year-EPS-Guidance</link>
<description></description>
<pubDate>Wed, 21 Oct 2026 07:30:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-10-21-Abbott-Reports-Third-Quarter-2026-Results-and-Reaffirms-Full-Year-EPS-Guidance</guid>
<enclosure url="https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Abbott Reports New Real-World Evidence Linking Cologuard® Screening to Lower Colorectal Cancer Incidence and Odds of Death</title>
<link>https://abbott.mediaroom.com/2026-10-12-Abbott-Reports-New-Real-World-Evidence-Linking-Cologuard-R-Screening-to-Lower-Colorectal-Cancer-Incidence-and-Odds-of-Death</link>
<description></description>
<pubDate>Mon, 12 Oct 2026 08:00:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-10-12-Abbott-Reports-New-Real-World-Evidence-Linking-Cologuard-R-Screening-to-Lower-Colorectal-Cancer-Incidence-and-Odds-of-Death</guid>
</item>
<item>
<title>Landmark study in people with Type 2 diabetes using basal insulin shows continuous glucose monitoring, including Abbott’s Libre technology, associated with lower risk of death and cardiovascular complications</title>
<link>https://abbott.mediaroom.com/2026-09-27-Landmark-study-in-people-with-Type-2-diabetes</link>
<description></description>
<pubDate>Sun, 27 Sep 2026 18:01:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-09-27-Landmark-study-in-people-with-Type-2-diabetes</guid>
</item>
<item>
<title>Abbott And Berry Street Partner To Expand Personalized Nutrition Support For Consumers Seeking Better Metabolic Health</title>
<link>https://abbott.mediaroom.com/2026-09-23-Abbott-And-Berry-Street-Partner-To-Expand-Personalized-Nutrition-Support-For-Consumers-Seeking-Better-Metabolic-Health</link>
<description></description>
<pubDate>Wed, 23 Sep 2026 07:00:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-09-23-Abbott-And-Berry-Street-Partner-To-Expand-Personalized-Nutrition-Support-For-Consumers-Seeking-Better-Metabolic-Health</guid>
<enclosure url="https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
<item>
<title>Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall</title>
<link>https://abbott.mediaroom.com/2026-09-14-Abbott-reaches-agreement-with-Department-of-Justice-to-resolve-claims-relating-to-2022-infant-formula-recall</link>
<description></description>
<pubDate>Mon, 14 Sep 2026 11:52:00 -0400</pubDate>
<guid>https://abbott.mediaroom.com/2026-09-14-Abbott-reaches-agreement-with-Department-of-Justice-to-resolve-claims-relating-to-2022-infant-formula-recall</guid>
<enclosure url="https://mma.prnewswire.com/media/2761216/Abbott_New_Logo.jpg?p=thumbnail" type="image/jpeg" />
</item>
</channel>
</rss>
